Coronavirus Vaccine Problems News ArticlesExcerpts of key news articles on coronavirus vaccine problems
Last spring, Israel's remarkably swift vaccination campaign was seen as a global model. Coronavirus infections plummeted, an electronic pass allowed the vaccinated to attend indoor concerts and sporting events, and distancing rules and mask mandates were eventually scrapped. Israel offered the world a hopeful glimpse of the way out of the pandemic. No longer. A fourth wave of infections is rapidly approaching the levels of Israel's worst days of the pandemic last winter. The daily rate of confirmed new virus cases has more than doubled in the last two weeks, making Israel a rising hot spot. Restrictions on gatherings and commercial and entertainment venues were reinstated this week, and the government is considering a new lockdown. Some experts fear that Israel's high rate of infections among early vaccine recipients may indicate a waning of the vaccine's protections over time. The vaccine may be less effective at preventing infection with the highly contagious Delta variant. The vast majority of Israel's older population had received two doses of the Pfizer-BioNTech vaccine by the end of February, and by now about 78 percent of the population 12 and older are fully vaccinated. Data published by Israel's Ministry of Health in late July suggested that the Pfizer shot was just 39 percent effective against preventing infection in the country in late June and early July, compared with 95 percent from January to early April.
Note: Whatever happened to the 95% efficacy of the Pfizer vaccine? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
For years, the Gates Foundation has been steered by an unusually small board of trustees, made up of Bill, his estranged wife, Melinda, and the billionaire investor Warren Buffett. The larger the foundation became, the less anyone seemed willing to ask tough questions about its secretive management structure or its penchant for giving money to lucrative pharmaceutical and credit card companies such as Mastercard, despite the fact that giving away billions to wealthy corporations set an unusual and troubling precedent in the philanthropic sector. Billionaires who make their fortunes through corporate practices that undercut workers and deepen inequality – like corporate tax avoidance, insufficient sick pay and the immoral gap in pay between executives and low-paid workers – are not the solution to problems they generate. Asking Bill Gates to fix inequality is like asking an arsonist to hose down your house after he just set it on fire. In April last year, the University of Oxford was reportedly considering offering a Covid-19 vaccine developed by its scientists on a nonexclusive basis. But then, Kaiser Health News reported, "Oxford – urged on by the Bill & Melinda Gates Foundation – reversed course. It signed an exclusive vaccine deal with AstraZeneca that gave the pharmaceutical giant sole rights and no guarantee of low prices." This dealmaking .. seemed to conflict with the Gates Foundation's stated mission to improve global access to medicines, but it's not surprising.
Note: Read more about the Gates Foundation's startling degree of media influence during the pandemic. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus vaccine from reliable major media sources.
Two health care workers at the same hospital in Alaska developed concerning reactions just minutes after receiving Pfizer's coronavirus vaccine this week, including one staff member who was to remain hospitalized until Thursday. The first worker, a middle-aged woman who had no history of allergies, had an anaphylactic reaction that began 10 minutes after receiving the vaccine. [After treatment] her symptoms subsided but then re-emerged, and she was treated with steroids and an epinephrine drip. When doctors tried to stop the drip, her symptoms re-emerged yet again, so the woman was moved to the intensive care unit. The second worker received his shot on Wednesday and developed eye puffiness, lightheadedness and a scratchy throat 10 minutes after the injection. He was taken to the emergency room and treated. The worker was back to normal within an hour and released. The hospital ... administered 144 total doses. The Alaska woman's reaction was believed to be similar to the anaphylactic reactions two health workers in Britain experienced after receiving the Pfizer-BioNTech vaccine last week. Like her, both recovered. Pfizer's trial did not find any serious adverse events caused by the vaccine, although many participants did experience aches, fevers and other side effects. [The CDC] has recommended that the vaccine be administered in settings that have supplies, including oxygen and epinephrine, to manage anaphylactic reactions.
Note: Does this sound like a safe vaccine? Remember that billions of dollars are involved here and Pfizer in the past was fined $2.3 billion dollars for illegal processes. How much can we trust them? More in this great article. And watch a video of a nurse fainting while being interviewed on TV minutes after getting the vaccine. For more, see concise summaries of deeply revealing news articles on problems with the coronavirus vaccines from reliable major media sources. Then explore the excellent, reliable resources provided in our Coronavirus Information Center.
Investment bankers have pressed health care companies on the front lines of fighting the novel coronavirus, including drug firms developing experimental treatments and medical supply firms, to consider ways that they can profit from the crisis. The largest voices in the health care industry stand to gain from billions of dollars in emergency spending on the pandemic, as do the bankers and investors who invest in health care companies. Over the past few weeks, investment bankers have been candid on investor calls and during health care conferences about the opportunity to raise drug prices. Executives joked about using the attention on Covid-19 to dodge public pressure on the opioid crisis. Health and Human Services Secretary Alex Azar previously served as president of the U.S. division of drug giant Eli Lilly and on the board of the Biotechnology Innovation Organization, a drug lobby group. During a congressional hearing ... Azar rejected the notion that any vaccine or treatment for Covid-19 should be set at an affordable price. "We can't control that price because we need the private sector to invest," said Azar. "The priority is to get vaccines and therapeutics. Price controls won't get us there." The initial $8.3 billion coronavirus spending bill passed in early March ... contained a provision that prevents the government from delaying the introduction of any new pharmaceutical to address the crisis over affordability concerns. The legislative text was shaped, according to reports, by industry lobbyists.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and President Biden's chief medical adviser, recently revealed he is experiencing a rebound of his Covid-19 infection after taking the antiviral medication Paxlovid. Fauci described the "interesting course" his own infection had taken on Tuesday during an appearance at Foreign Policy's Global Health Forum. "I turned positive about two weeks ago, with very minimal symptoms. When they increased, given my age, I went on Paxlovid for five days," Fauci said. Fauci, 81, credited the drug with keeping him out of the hospital. After five days on the drug, he tested negative. He had three consecutive days of negative tests. On the fourth day he tested positive again. "It was sort of what people are referring to as a Paxlovid rebound," he said. The CDC issued a health alert to doctors on May 24, advising that Covid-19 symptoms sometimes come back, and that may just be how the infection plays out in some people, regardless of whether they're vaccinated or treated with medications like Paxlovid. In Fauci's case, he said his symptoms got worse when they returned after treatment. "Over the next day or so I started to feel really poorly, much worse than in the first go around," he said. His doctors prescribed another course of Paxlovid. "I went back on Paxlovid, and right now I am on my fourth day of a five-day course of my second course of Paxlovid. Fortunately, I feel reasonably good. I mean, I'm not completely without symptoms, but I certainly don't feel acutely ill."
Note: So two Pfizer shots and two boosters couldn't keep Fauci from getting COVID not once, but twice. And he says the reason he managed to avoid the hospital is not because of the four shots, but because of the new antiviral he is promoting. This certainly is an "interesting course" as he himself describes it. So how effective are these many injections so strongly promoted by Fauci, the CDC and others. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
A year ago, just two doses of a Covid-19 vaccine – or even one, in the case of Johnson & Johnson's formulation – were thought to offer sufficient protection against the coronavirus. On Wednesday, the Centers for Disease Control and Prevention expanded eligibility for boosters to adolescents and backed away from describing anyone as "fully vaccinated" because two shots no longer seem adequate. Instead, one's vaccination status will now be "up to date" – or not. It's no surprise that many Americans are wondering: Where does this end? Are we to roll up our sleeves for booster shots every few months? Scientists are reluctant to predict the future. But in interviews this week, nearly a dozen said that whatever happens, trying to boost the entire population every few months is not realistic. Nor does it make much scientific sense. For starters, persuading people to line up for shots every few months is probably a losing proposition. Just as important, there are no data to support the effectiveness of a fourth dose of the current vaccines. If the coronavirus settles into a flulike seasonal pattern, as it seems possible, "you can imagine a scenario where we simply give boosters before the winter each year," Dr. Hensley said. Lessons from flu season also suggest that frequent vaccination is unlikely to be helpful. Giving the flu vaccine twice a year "has a diminishing return, and so it may not make sense to do vaccination so frequently," said [epidemiologist] Ben Cowling.
Note: Could it be that this is what big Pharma has been hoping for all along - forever boosting? And if it's all free, you won't even see how billions of your tax dollars are flowing into the pockets of the elite. Could this be why the Australian government on their website stated they are securing 195 million doses of COVID vaccine boosters for their population of 25 million? For more, see this revealing article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
More than 500 residents in Oregon have now died of COVID-19 despite being fully vaccinated against the virus as health officials continue to report over 2,000 new infections daily. Since the beginning of the pandemic, health authorities in Oregon have recorded a total of 552 breakthrough COVID-19 deaths throughout the state. Of the total number of deaths, 273 people had been fully vaccinated with the Pfizer COVID-19 vaccine. At least 144 received the Moderna vaccine and 78 were given the Johnson & Johnson shots. The recent report also showed that there were 4,134 new COVID-19 cases recorded between Nov. 21 and Nov. 27. At least 1,186 were breakthrough infections. As of Dec. 2, Oregon reported a total of 45,545 coronavirus infections among the fully vaccinated. The Oregon Health Authority's report comes as the state continues to report high rates of COVID-19 cases. Over the past weekend, health officials recorded 2,041 new infections and 25 additional deaths.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Ministers have agreed [to] a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britain's Covid vaccine supply. Large portions of the government's contracts with the company over the supply of 189m vaccine doses have been redacted and any arbitration proceedings will be kept secret. The revelation comes as Pfizer is accused by a former senior US health official of "war profiteering'' during the pandemic. Tom Frieden, who was director of the US Centers for Disease Control and Prevention under Barack Obama, said: "If you're just focusing on maximising your profits and you're a vaccine manufacturer ... you are war profiteering." Zain Rizvi, research director at Public Citizen, a US consumer advocacy organisation which has examined Pfizer's global vaccine contracts, said: "There is a wall of secrecy surrounding these contracts and it's unacceptable, particularly in a public health crisis." Rizvi said the UK needed to explain why it had agreed to secret arbitration proceedings. He said: "It's the only high-income country we have seen that has agreed to this provision. It allows pharmaceutical companies to bypass domestic legal processes." While AstraZeneca agreed to sell its vaccine at cost during the pandemic, Pfizer wanted to secure its profits. The Pfizer/BioNTech vaccine ... will be one of the most lucrative drugs in pharmaceutical history. One biological engineering expert [claims] the Pfizer vaccine costs just 76p to manufacture for each shot. It is reportedly being sold for Ł22 a dose to the UK government.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Massachusetts on Tuesday reported 4,378 more COVID-19 cases among fully vaccinated people since last week, bringing the total since the beginning of the vaccination campaign to 36,723 cases, or 0.8 percent of all fully vaccinated people. The Department of Public Health also reported 37 more COVID-19 deaths among fully vaccinated people, bringing the total to 254 deaths among those fully vaccinated. The department also reported 154 more hospitalizations among fully vaccinated people, for a total of 1,155 hospitalizations. State officials and public health experts have repeatedly stressed that vaccination greatly reduces hospitalization, severe illness, and death as a result of COVID-19. As of Tuesday, 4,619,950 people in Massachusetts have been fully vaccinated, according to the department.
Note: Massachusetts has a population of nearly 7 million, or 1/50th of the U.S. So if it is representative of the entire country, 254 X 50 = 12,200 deaths among fully vaccinated people in the U.S. Indiana, also with a population of about 7 million, reports 229 fully vaccinated citizens have died, again suggesting well over 10,000 fully vaccinated COVID deaths in the U.S. Why isn't this being reported? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
More than 30,000 residents in Indiana have contracted COVID-19 and over 200 have died of the novel coronavirus despite being fully vaccinated against the disease. Indiana health officials have recorded 33,851 breakthrough COVID-19 cases among the state's fully vaccinated individuals since the beginning of the pandemic. The health department's data also showed that 229 fully vaccinated residents have died of COVID-19. Of the 229 deaths, 92% or 210 occurred in patients aged 65 or older. As of Thursday, health officials have also reported 735 breakthrough COVID-19 hospitalizations. Overall, the state has recorded 959,409 COVID-19 cases since the start of the pandemic. Indiana also reported 65 new deaths that occurred between Aug. 25 and Sept. 28, bringing Indiana's total number of COVID-19 deaths to 15,132. Indiana health officials have fully vaccinated 56% of eligible residents, including more than 70% of people aged 60 and older. However, only 3.7% of children between the ages of 12 to 15 have been fully vaccinated against COVID-19, and only 4.3% of people from the same age group have received their first doses.
Note: Is it just a coincidence that shortly after this became news, the Indiana Department of Health suspended daily COVID-19 case reports? Massachusetts has a population of 6.7 million, or about 1/50th of the U.S. So if it is representative of the entire country, 229 X 50 = 11,450 deaths among fully vaccinated people in the U.S. Massachusetts, also with about 7 million, reports 254 fully vaccinated citizens have died, again suggesting over 10,000 vaccinated COVID deaths. Why isn't this being reported? For more, see summaries of revealing news articles on coronavirus vaccines.
The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren't profiteering from their monopolies on COVID-19 vaccines, campaigners from the People's Vaccine Alliance said today. New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production. Colombia, for example, has potentially overpaid by as much as $375 million for its doses of the Pfizer/BioNTech and Moderna vaccines, in comparison to the estimated cost price. Despite a rapid rise in COVID-19 cases and deaths across the developing world, Pfizer/BioNTech and Moderna have sold over 90 percent of their vaccines so far to rich countries, charging up to 24 times the potential cost of production. Last week Pfizer/BioNTech announced it would licence a South African company to fill and package 100 million doses for use in Africa, but this is a drop in the ocean of need. Neither company have agreed to fully transfer vaccine technology and know-how with any capable producers in developing countries, a move that could increase global supply, drive down prices and save millions of lives. Analysis of production techniques for the leading mRNA type vaccines produced by Pfizer/BioNTech and Moderna Ă˘â‚Źâ€˘which were only developed thanks to public funding to the tune of $8.3 billionĂ˘â‚Źâ€˘ suggest these vaccines could be made for as little as $1.20 a dose.
President Joe Biden's administration is being asked to punish Hungary, Colombia, Chile, and other countries for seeking to ramp up the production of Covid-19 vaccines and therapeutics without express permission from pharmaceutical companies. The sanctions are being urged by the drug industry, which has filed hundreds of pages of documents to the Office of the U.S. Trade Representative outlining the alleged threat posed by any effort to challenge "basic intellectual property protections" in the response to the coronavirus pandemic. The drug industry has sharply criticized any attempt to share vaccine patents or the technological knowledge needed to manufacture them, despite global need. The strident corporate opposition to any intellectual property flexibility has rankled public health advocates, many of whom note that much of the vaccine technology has been financed by the public sector. The Pfizer vaccine, noted Prabhala, was developed in partnership with the European firm BioNTech, which received $445 million from the German government to help accelerate vaccine development and manufacturing. The U.S. government provided about $1 billion for the research and testing by Moderna to create its coronavirus vaccine. Johnson & Johnson received over $1.45 billion in funding from the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services, for its recently approved Covid-19 vaccine.
Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans' protection against the virus. The Biden administration last month announced plans to give boosters to nearly everybody. But U.S. regulators have rejected the across-the-board approach and instead said third shots of Pfizer's vaccine should go to people who are 65 and older and certain others at high risk from COVID-19. Still ... some top U.S. health officials expect boosters will be more broadly authorized in the coming weeks or months. And that, plus continued growth in initial vaccinations, could mean a huge gain in sales and profits for Pfizer and Moderna in particular. Wall Street is taking notice. The average forecast among analysts for Moderna's 2022 revenue has jumped 35% since President Joe Biden laid out his booster plan in mid-August. Most of the vaccinations so far in the U.S. have come from Pfizer, which developed its shot with Germany's BioNTech, and Moderna. No one knows yet how many people will get the extra shots. But Morningstar analyst Karen Andersen expects boosters alone to bring in about $26 billion in global sales next year for Pfizer and BioNTech and around $14 billion for Moderna if they are endorsed for nearly all Americans. Drugmakers ... say people might need annual shots like the ones they receive for the flu. All of that could make the vaccines a major recurring source of revenue.
Note: Learn lots more about the huge profits of big Pharma from COVID in this revealing article. Listen to first hand tragic stories of those who died or were seriously injured by COVID injections. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
What Americans need to understand about the race to find vaccines and treatments for Covid-19 is that in the U.S., even when companies appear to downshift from maximum greed levels – and it's not at all clear they've done this with coronavirus treatments – the production of pharmaceutical drugs is still a nearly riskless, subsidy-laden scam. Americans reacted in horror five years ago when a self-satisfied shark of an executive named Martin Shkreli, a.k.a. the "Pharma Bro," helped his company, Turing Pharmaceuticals, raise the price of lifesaving toxoplasmosis drug Daraprim from $13.50 to $750 per pill. Shkreli, who smirked throughout congressional testimony ... was held up as a uniquely smug exemplar of corporate evil. Really, the whole industry is one big Shkreli, and Covid-19 – a highly contagious virus with unique properties that may require generations of vaccinations and booster shots – looms now as the ultimate cash cow for lesser-known Pharma Bros. "The power of the industry combined with fear is driving extraordinary spending," says U.S. Rep. Lloyd Doggett (D-Texas), who has been ... warning about pandemic profiteering. "It all suggests rosy times ahead for the pharmaceutical industry." Recent House and Senate emergency-spending bills allocate as much as $20 billion or more for vaccine development, and another $6 billion for manufacturing and distribution. "The public will pay for much research and manufacturing," says Doggett. "Only the profits will be privatized."
When pharmaceutical company Moderna issued a press release about the promising results of its Phase I clinical trial for a coronavirus vaccine, the media and the markets went wild. Upon examining Moderna's non-peer reviewed press release, the actual data on the vaccine's success is ... flimsy. Of the 45 patients who received the vaccine, the data on "neutralising antibody data are available only for the first four participants in each of the 25-microgram and 100-microgram dose level cohorts." In other words, that means that when it comes to finding out whether the vaccine elicits an antibody response that could potentially fight the coronavirus, they only had data on eight patients. That's not enough to do any type of statistical analysis and it also brings into question the status of the other 37 patients who also received the vaccine. Moderna's messenger RNA vaccine ... uses a sequence of genetic RNA material produced in a lab that, when injected into your body, must invade your cells and hijack your cells' protein-making machinery called ribosomes to produce the viral components that subsequently train your immune system to fight the virus. There are unique and unknown risks to messenger RNA vaccines, including the possibility that they generate strong type I interferon responses that could lead to inflammation and autoimmune conditions. Messenger RNA vaccines have never before been brought to market for human patients.
Note: To learn about the serious risks and dangers of these mRNA vaccines, don't miss the vitally important information given by Christiane Northrup, MD, in the first five minutes of this highly revealing video. Reader's Digest named Dr. Northrup one of "The 100 Most Trusted People in America." Dr. Northrup's work has been featured on The Oprah Winfrey Show, the Today Show, NBC Nightly News, Good Morning America, 20/20, and The Dr. Oz Show. For more, see concise summaries of revealing news articles on the coronavirus and vaccines from major media sources.
European Union regulators warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency. Instead, countries should leave more time between booster programs and tie them to the onset of the cold season in each hemisphere, following the blueprint set out by influenza vaccination strategies, the agency said. The advice comes as some countries consider the possibility of offering people second booster shots in a bid to provide further protection against surging omicron infections. Earlier this month Israel became the first nation to start administering a second booster, or fourth shot, to those over 60. The U.K. has said that boosters are providing good levels of protection and there is no need for a second booster shot at the moment, but will review data as it evolves. Boosters "can be done once, or maybe twice, but it's not something that we can think should be repeated constantly," Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. "We need to think about how we can transition from the current pandemic setting to a more endemic setting."
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Strong sales of its COVID-19 vaccine and other medicines helped Pfizer nearly double its second-quarter revenue and boost its profit an impressive 59%, beating Wall Street expectations and leading the drug giant to sharply hike its 2021 sales and profit forecasts. Amid the surging coronavirus pandemic, the COVID-19 vaccine became Pfizer's top seller, bringing in nearly half its revenue – $7.84 billion from direct sales and revenue split with its partner, Germany's BioNTech. Pfizer now anticipates revenue from the two-dose vaccine this year to reach $33.5 billion for the 2.1 billion doses it's contracted to provide by year end. That doesn't include a contract struck last week to provide an additional 200 million doses to the U.S. The New York company on Wednesday disclosed that ongoing testing of a booster shot, given six months after the second vaccine dose, showed it raised antibody levels against the more-transmissible Delta variant to 11 times higher in older people and five times higher in younger people, compared to levels after two doses. Pfizer has delivered more than 1 billion doses of the vaccine globally and expects to make 3 billion doses this year, with many more going to low- and middle-income countries from now through year's end. Most doses of all the COVID-19 vaccines produced in Europe and the U.S. so far have gone to wealthy countries.
Note: When public health is at stake, should private companies be making huge profits like this? Read more in this information article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.
Across the pharmaceutical and medical industries, senior executives and board members are making millions of dollars after announcing positive developments, including support from the government, in their efforts to fight Covid-19. After such announcements, insiders from at least 11 companies – most of them smaller firms whose fortunes often hinge on the success or failure of a single drug – have sold shares worth well over $1 billion since March, according to figures compiled for The New York Times. The sudden windfalls highlight the powerful financial incentives for company officials to generate positive headlines in the race for coronavirus vaccines and treatments, even if the drugs might never pan out. Some officials at the Department of Health and Human Services have grown concerned about whether companies are trying to inflate their stock prices by exaggerating their roles in Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19. In some cases, company insiders ... appear to be pouncing on opportunities to cash out while their stock prices are sky high. And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. "It is inappropriate for drug company executives to cash in on a crisis," said Ben Wakana, executive director of Patients for Affordable Drugs. "Every day, Americans wake up and make sacrifices during this pandemic. Drug companies see this as a payday."
In the USA and Germany, high-level officials have used the term pandemic of the unvaccinated, suggesting that people who have been vaccinated are not relevant in the epidemiology of COVID-19. Officials' use of this phrase might have encouraged one scientist to claim that "the unvaccinated threaten the vaccinated for COVID-19". But this view is far too simple. There is increasing evidence that vaccinated individuals continue to have a relevant role in transmission. In Massachusetts, USA, a total of 469 new COVID-19 cases were detected during various events in July, 2021, and 346 (74%) of these cases were in people who were fully or partly vaccinated, 274 (79%) of whom were symptomatic. Cycle threshold values were similarly low between people who were fully vaccinated (median 22·8) and people who were unvaccinated, not fully vaccinated, or whose vaccination status was unknown (median 21·5), indicating a high viral load even among people who were fully vaccinated. In MĂĽnster, Germany, new cases of COVID-19 occurred in at least 85 (22%) of 380 people who were fully vaccinated or who had recovered from COVID-19 and who attended a nightclub. People who are vaccinated have a lower risk of severe disease but are still a relevant part of the pandemic. It is therefore wrong and dangerous to speak of a pandemic of the unvaccinated. Historically, both the USA and Germany have engendered negative experiences by stigmatising parts of the population.
Indiana's largest hospital system says more than 100 workers are no longer employed with the health network after they did not comply with its mandate for all employees to get vaccinated against COVID-19. Indiana University Health said Thursday that 125 employees had departed from the hospital system after a two-week unpaid suspension period that ended Sept. 14. Officials did not say whether those workers quit or were fired, saying in a statement that they "chose not to receive the COVID-19 vaccine and have left the organization." IU Health did not provide details on what kinds of positions were affected, or whether any of the employees worked in bedside care. The 125 former employees were a small percentage of IU Health's work force of about 36,000. IU Health announced in June that it would require all its doctors, nurses and other employees to be fully vaccinated against COVID-19 by Sept. 1. The health system operates 15 hospitals and dozens of outpatient clinics around the state. Two weeks ago, IU Health said suspended employees would be allowed to return to work if they attested to partial or full vaccination. At the time, it said that fewer than 300 workers had been suspended. Around the U.S., more than 150 hospital systems have issued vaccination mandates to employees. Hospitals have borne the brunt of the recent surge in COVID-19 cases.
Note: These 125 health workers and many thousands of others were heroes one year ago for risking their lives in service of those suffering from COVID. Now they are being fired for refusing having a foreign substance injected into their bodies. And notice the almost Orwellian language in the title of this article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.